Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kristopher S Denby

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
Current Opinion in Allergy and Clinical Immunology|May 25, 2012
Update on systemic therapies for atopic dermatitisKristopher S Denby, Lisa A Beck
Applied Immunohistochemistry & Molecular Morphology : AIMM|April 13, 2012
IMP3, NESP55, TTF-1 and CDX2 serve as an immunohistochemical panel in the distinction among small-cell carcinoma, gastrointestinal carcinoid, and pancreatic endocrine tumor metastasized to the liverKristopher S Denby, Alice J Briones, Patricual A Bourne, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
Current Opinion in Allergy and Clinical Immunology|May 25, 2012
Update on systemic therapies for atopic dermatitisKristopher S Denby, Lisa A Beck
Applied Immunohistochemistry & Molecular Morphology : AIMM|April 13, 2012
IMP3, NESP55, TTF-1 and CDX2 serve as an immunohistochemical panel in the distinction among small-cell carcinoma, gastrointestinal carcinoid, and pancreatic endocrine tumor metastasized to the liverKristopher S Denby, Alice J Briones, Patricual A Bourne, et al.
Pageof 1